524314 — Gujarat Terce Laboratories Income Statement
0.000.00%
Last trade - 00:00- IN₹412.64m
- IN₹404.15m
- IN₹501.95m
- 54
- 48
- 32
- 40
Annual income statement for Gujarat Terce Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 252 | 401 | 468 | 480 | 502 |
| Cost of Revenue | |||||
| Gross Profit | 152 | 249 | 274 | 303 | 313 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 281 | 393 | 493 | 471 | 467 |
| Operating Profit | -29.4 | 8.42 | -25.2 | 8.99 | 35 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -25.3 | 7.47 | -28.9 | 5.44 | 33.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -25.2 | 8.72 | -16.7 | 2.43 | -9.79 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -25.2 | 8.72 | -16.7 | 2.43 | -9.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.2 | 8.72 | -16.7 | 2.43 | -9.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.4 | 1.18 | -2.25 | 0.328 | -1.31 |
| Dividends per Share |